On 23 November 2022, David Busse successfully defended his doctoral thesis entitled “Towards precision dosing in morbidly obese patients: Complementary pharmacometric approaches to characterise antibiotic target-site exposure”. We warmly congratulate and wish David Busse all the best for his future.